Sangamo BioSciences beats by $0.04, beats on revenue

Sangamo BioSciences (NASDAQ:SGMO): Q2 EPS of -$0.10 beats by $0.04.

Revenue of $10.38M (+49.8% Y/Y) beats by $2.54M.

From other sites
Comments (1)
  • MineMan
    , contributor
    Comments (601) | Send Message
    Excellent call.
    everyone interested in SGMO should listen to the webcast at least twice.
    IND filings in the summer 2014.
    2 additional filings EOY 2014.
    23 Jul 2014, 05:46 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs